A non-inferiority study evaluating a new extended-release preparation of tilmicosin injected subcutaneously vs. ceftiofur administered intramammary, as dry-cow therapy in Holstein Friesian cows.
Esteban OrtegaEdgar Alfonseca-SilvaEduardo PosadasGraciela Tapia-PérezHéctor SumanoPublished in: Journal of veterinary science (2021)
This study is the first successful report of parenteral DCT showing comparable efficacy as CEF, the gold-standard. The extended long-term pharmacokinetic activity of TLAe explains these results.